Researchers have found that transplanting specific gut viruses into obese mice can sharply improve how those animals regulate ...

Global immunity to Covid-19 is likely to offer protection against other SARS-type viruses, ultimately lowering the risk of a ...

The University of Delaware’s University Studies course guides first-year students through faculty interviews and student ...

Global immunity to COVID-19 is likely to offer protection against the emergence of an as yet undiscovered new SARS-type virus, dubbed SARS-CoV-X, ultimately lowering the risk of a future coronavirus p ...

Gilead will pay $1.675 billion upfront plus up to $500 million in milestones to obtain OM336, positioning BCMA-targeted ...

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results ...

Sarepta Therapeutics is navigating a transition from a profitable rare-disease company to a capital-intensive, multi-platform ...

But his brain stubbornly remains at the anatomic age of 42. “The brain is really hard to rejuvenate,” he lamented on ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat adults with moderate-to-severe bullous pemphigoid: Paris Wednesday, March 25, 2026, 09:00 Hrs [IST] T ...

General Secretary of the Communist Party of Vietnam Central Committee To Lam has underscored the vital role played by young ...

Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...